Vivo Opportunity Fund Holdings, L.P., 10% Owner at Terns Pharmaceuticals, Inc. (TERN), bought 758,620 shares at $7.25 ($5.5M) on 2022-12-23, disclosed to the SEC on 2022-12-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |